BR102012022291B8 - Processo de fabricação de produto para tratamento da psoríase - Google Patents

Processo de fabricação de produto para tratamento da psoríase

Info

Publication number
BR102012022291B8
BR102012022291B8 BR102012022291A BR102012022291A BR102012022291B8 BR 102012022291 B8 BR102012022291 B8 BR 102012022291B8 BR 102012022291 A BR102012022291 A BR 102012022291A BR 102012022291 A BR102012022291 A BR 102012022291A BR 102012022291 B8 BR102012022291 B8 BR 102012022291B8
Authority
BR
Brazil
Prior art keywords
psoriasis
treatment
product
manufacturing process
vitamin
Prior art date
Application number
BR102012022291A
Other languages
English (en)
Other versions
BR102012022291A2 (pt
BR102012022291B1 (pt
Inventor
José Trassi Antonio
Original Assignee
Antonio Jose Trassi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50236391&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR102012022291(B8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Antonio Jose Trassi filed Critical Antonio Jose Trassi
Priority to BR102012022291A priority Critical patent/BR102012022291B8/pt
Priority to PCT/BR2013/000343 priority patent/WO2014036620A1/pt
Publication of BR102012022291A2 publication Critical patent/BR102012022291A2/pt
Publication of BR102012022291B1 publication Critical patent/BR102012022291B1/pt
Publication of BR102012022291B8 publication Critical patent/BR102012022291B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

processo de fabricação de produto para tratamento da psoríase e produto papa tratamento da psoríase, apresentados no presente pedido de patente de invenção, compreendem processo de fabricação e produto que pela natureza inócua de seus componentes, não oferece, em absoluto, nenhum risco à saúde dos pacientes e possui excelente relação custo - benefício; referido processo e produto para tratamento da psoríase compreendem os compostos: alfa-bisabolol, vitamina a, vitamina e, ácido salicílico, alantoína, camomila, óleo de copaíba, aloe vera, loção base não iônica polawax, e opcionalmente os componentes: extrato de arnica, óleo de girassol e petrolatum líquido.
BR102012022291A 2012-09-04 2012-09-04 Processo de fabricação de produto para tratamento da psoríase BR102012022291B8 (pt)

Priority Applications (2)

Application Number Priority Date Filing Date Title
BR102012022291A BR102012022291B8 (pt) 2012-09-04 2012-09-04 Processo de fabricação de produto para tratamento da psoríase
PCT/BR2013/000343 WO2014036620A1 (pt) 2012-09-04 2013-09-04 Processo de fabricação de produto para tratamento da psoríase e produto para tratamento da psoríase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR102012022291A BR102012022291B8 (pt) 2012-09-04 2012-09-04 Processo de fabricação de produto para tratamento da psoríase

Publications (3)

Publication Number Publication Date
BR102012022291A2 BR102012022291A2 (pt) 2015-01-20
BR102012022291B1 BR102012022291B1 (pt) 2021-02-02
BR102012022291B8 true BR102012022291B8 (pt) 2022-03-15

Family

ID=50236391

Family Applications (1)

Application Number Title Priority Date Filing Date
BR102012022291A BR102012022291B8 (pt) 2012-09-04 2012-09-04 Processo de fabricação de produto para tratamento da psoríase

Country Status (2)

Country Link
BR (1) BR102012022291B8 (pt)
WO (1) WO2014036620A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2551281B1 (es) * 2014-05-14 2016-09-14 José RAMOS PRIETO Producto en crema de uso tópico para el tratamiento de enfermedades de la piel y procedimiento de obtención

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20020756A1 (it) * 2002-04-09 2003-10-09 Sinclair Pharma S R L Composizioni farmaceutiche topiche per il trattamento delle dermatiti
GB201019297D0 (en) * 2010-11-15 2010-12-29 Pitt Elaine Improved compositions

Also Published As

Publication number Publication date
WO2014036620A1 (pt) 2014-03-13
BR102012022291A2 (pt) 2015-01-20
BR102012022291B1 (pt) 2021-02-02

Similar Documents

Publication Publication Date Title
CL2014000314A1 (es) Compuestos derivados de ciclopropanamina, inhibidores de desmetilasa especifica de lisina 1 (lsd1); medicamento que los comprende; metodo para profilaxis o tratamiento; metodo para inhibir lsd1; y su uso en la profilaxis o tratamiento de esquizofrenia, enfermedad de alzheimer, enfermedad de parkinson o corea de huntington.
CR20140327A (es) Pirimidinas y triazinas fusionadas sustituidas y su uso
EA201791299A1 (ru) Микроинкапсулированные композиции каннабиноидов
MX2016007067A (es) Microcapsulas lipidicas que comprenden de preferencia un retinoide y composicion que las contiene, su procedimiento de preparacion y su uso en dermatologia.
BR112016009889A2 (pt) ?compostos agonistas duplos gip-glp-1 e métodos?
BR112015005369A2 (pt) inibidores de usp30 e métodos para sua utilização
CR20140554A (es) Compuestos de acido dimetil-benzoico
CL2016000382A1 (es) Procesos para preparar compuestos antivirales
CL2016001076A1 (es) (aza) piridopirazolopirimidinonas e indazolopirimidinonas como inhibidores de fibrinolosis.
BR112015030543A2 (pt) glicerol formador de película para aplicação tópica
FR2991171B1 (fr) Procede de preparation d'une composition dermatologique comprenant des oleosomes
BR112016009605A2 (pt) Uso antiinflamatório de fitocomplexos líquidos a partir de azeitona
DOP2012000250A (es) COMPUESTOS DEL COMPLEJO DE Fe(III) PARA EL TRATAMIENTO Y PROFILAXIS DE LOS SÍNTOMAS DE DEFICIENCIA DE HIERRO Y LAS ANEMIAS POR DEFICIENCIA DE HIERRO
CO7071140A2 (es) Composición topica semisolida conteniendo pirfenidona y dialil oxido de disulfuro modificado (odd-m) para eliminar o prevenir el acne
BR112016009606A2 (pt) Uso antiangiogênico de fitocomplexos líquidos a partir de azeitona
GT201400242A (es) "nuevos compuestos de pirazol"
BR112019001366A2 (pt) catalisadores para a produção de ácido acrílico a partir de ácido lático ou seus derivados em fase líquida
CL2017000231A1 (es) Arilhidrazidas que contienen una fracción de 2-piridona como agentes antibacterianos selectivos
LV15002A (lv) Heterociklā aizvietoti [(2-karboksi vai -metoksikarbonil)fenilkarbamoil-metil (vai trimetilēn)] piridīnija vai izohinolīnija bromīdi kā hidroksikarbonskābju receptoru saimes (HCA2) jauna ligandu klase
BR112016007238A2 (pt) tienouracilcarboxamidas cíclicas e sua utilização
BR112015022513A2 (pt) produto e método para tratamento de diarreia
BR112015014885A2 (pt) combinação de agentes ativos, composição cosmética e/ou dermatológica e processo para a preparação de uma composição de agentes ativos.
BR112014017587A2 (pt) métodos e formulações para o tratamento de deficiências de ácido siálico
BR112012014658A2 (pt) uso de 2,3-di-hidroxipropil dodecanoato para o tratamento da seborreia
BR112015027629A2 (pt) Inibidores de nicotinamido fosforribosiltransferase, composições, produtos e seus usos

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A ANUIDADE.

B08G Application fees: restoration [chapter 8.7 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 04/09/2012, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REF. RPI 2613 DE 02/02/2021 QUANTO AO TITULO.